1. Introduction
===============

Many benzoxazolinone derivatives have been described in therapeutics as possessing a wide variety of pharmacological activities \[[@B1-molecules-20-01262],[@B2-molecules-20-01262],[@B3-molecules-20-01262],[@B4-molecules-20-01262],[@B5-molecules-20-01262],[@B6-molecules-20-01262],[@B7-molecules-20-01262],[@B8-molecules-20-01262],[@B9-molecules-20-01262],[@B10-molecules-20-01262]\]. Indeed, the clinical applications of this template are very broad, and range from analgesic anti-inflammatory compounds to antipsychotic and neuroprotective anticonvulsant compounds \[[@B11-molecules-20-01262]\]. Several potentially useful drugs and pharmacological tools based on these pharmacophores have been developed in recent years \[[@B12-molecules-20-01262],[@B13-molecules-20-01262],[@B14-molecules-20-01262],[@B15-molecules-20-01262],[@B16-molecules-20-01262]\].

Tetrakis(dimethylamino)ethylene (TDAE) is a reducing agent which reacts with halogenated derivatives to generate an anion under mild conditions via two sequential transfers of one electron \[[@B17-molecules-20-01262],[@B18-molecules-20-01262],[@B19-molecules-20-01262]\]. Through this strategy, we have developed many reactions between nitrobenzylic substrates and a series of electrophiles such as aldehydes, ketones, α-ketoesters, α-ketolactams and ketomalonates leading to corresponding alcohol adducts \[[@B20-molecules-20-01262],[@B21-molecules-20-01262],[@B22-molecules-20-01262],[@B23-molecules-20-01262]\]. This reactivity was recently extended using original heterocyclic carbaldehydes as electrophiles. The reactions led to the expected products, while at the same time bringing to light a new and original reactivity and enabling us to define some limitations of this strategy \[[@B24-molecules-20-01262]\]. Moreover, we reported the reactions of dihalo- and trihalomethyl heterocyclic derivatives with aromatic aldehydes in the presence of TDAE, providing a mixture of *cis*/*trans* isomers of oxiranes and α-haloketone derivatives, respectively \[[@B25-molecules-20-01262],[@B26-molecules-20-01262]\]. In the same context, the expected alcohols and oxiranes were obtained in good yields in the quinonic series \[[@B27-molecules-20-01262]\].

In continuation of our research program centered on the design and synthesis of novel bioactive molecules \[[@B28-molecules-20-01262],[@B29-molecules-20-01262],[@B30-molecules-20-01262],[@B31-molecules-20-01262],[@B32-molecules-20-01262]\], we report herein the preparation of 5-(bromomethyl)-3-methyl-6-nitrobenzoxazolone (**2**) and 5-(dibromomethyl)-3-methyl-6-nitrobenzoxazolone (**3**) and the study of their reactivity with various aromatic carbonyl and α-carbonyl ester derivatives using the TDAE methodology.

2. Results and Discussion
=========================

2.1. Synthesis of Mono and Dibromide Substrates
-----------------------------------------------

We prepared 5-(bromomethyl)-3-methyl-6-nitrobenzoxazolone (**2**) and 5-(dibromomethyl)-3-methyl-6-nitrobenzoxazolone (**3**) \[[@B33-molecules-20-01262]\] in four and five steps, respectively. The condensation of 2-amino-4-methylphenol with urea was inspired by a previously described method \[[@B34-molecules-20-01262],[@B35-molecules-20-01262]\]. After methylation using dimethyl sulfate, the nitration of the obtained 3,5-dimethylbenzoxazolone by action of a mixture of nitric and sulfuric acids afforded 3,5-dimethyl-6-nitrobenzoxazolone (**1**) in 88% yield.

![Synthesis of 5-(bromomethyl)-3-methyl-6-nitrobenzoxazolone (**2**) and 5-(dibromomethyl)-3-methyl-6-nitrobenzoxazolone (**3**).](molecules-20-01262-g001){#molecules-20-01262-f001}

The bromination of **1** with 2 equivalents of *N*-bromosuccinimide in refluxing CCl~4~ for 8.5 h gave 5-(bromomethyl)-3-methyl-6-nitrobenzoxazolone (**2**) in 61% yield, accompanied by 5-(dibromomethyl)-3-methyl-6-nitrobenzoxazolone (**3**) in 38% yield. However, the preparation of this latter compound was optimized (76%) using 6 equivalents of *N*-bromosuccinimide in refluxing CCl~4~ for 10 h ([Scheme 1](#molecules-20-01262-f001){ref-type="scheme"}).

2.2. TDAE Reactivity of 5-(Bromomethyl)-3-methyl-6-nitrobenzoxazolone (**2**)
-----------------------------------------------------------------------------

The reaction of 5-(bromomethyl)-3-methyl-6-nitrobenzoxazolone (**2**) with 3 equivalents of various aromatic carbonyl and α-carbonyl ester derivatives **4a**--**j** in the presence of TDAE at −20 °C for 1 h, followed by 2 h at room temperature (r.t.) led to the corresponding alcohol derivatives **5a**--**j** in moderate to good yields (31%--72%) as shown in [Table 1](#molecules-20-01262-t001){ref-type="table"} and [Scheme 2](#molecules-20-01262-f002){ref-type="scheme"}.

molecules-20-01262-t001_Table 1

###### 

Reaction of bromide **2** with aromatic carbonyl and α-carbonyl ester derivatives using TDAE ^a^.

  Entry ^a^   Aromatic Carbonyl      *R*~1~             *R*~2~          Product Number   Yield (%) ^b^
  ----------- ---------------------- ------------------ --------------- ---------------- ---------------
  **1**       4-Nitrobenzaldehyde    4-NO~2~-C~6~H~4~   H               **5a**           52
  **2**       4-Bromobenzaldehyde    4-Br-C~6~H~4~      H               **5b**           49
  **3**       4-Cyanobenzaldehyde    4-CN-C~6~H~4~      H               **5c**           31
  **4**       2-Nitrobenzaldehyde    2-NO~2~-C~6~H~4~   H               **5d**           44
  **5**       2-Bromobenzaldehyde    2-Br-C~6~H~4~      H               **5e**           49
  **6**       3-Bromobenzaldehyde    3-Br-C~6~H~4~      H               **5f**           43
  **7**       Ethyl glyoxylate       CO~2~C~2~H~5~      H               **5g**           72
  **8**       Diethyl ketomalonate   CO~2~C~2~H~5~      CO~2~C~2~H~5~   **5h**           62

Notes: ^a^ All the reactions were performed using 3 equivalents of aromatic carbonyl **4a**--**h**, 1 equivalent of bromide **2** and 1 equivalent of TDAE in anhydrous DMF stirred at −20 °C for 1 h and then warmed to rt for 2 h; ^b^ % Yield relative to bromide **2**.

![TDAE reactivity of 5-(bromomethyl)-3-methyl-6-nitrobenzoxazolone (**2**) with aromatic carbonyl and some α-keto-ester derivatives **4a**--**h**.](molecules-20-01262-g002){#molecules-20-01262-f002}

The reaction of substrate **2** with the aromatic aldehydes **4a**--**f** under TDAE-initiated conditions furnished the expected alcohols **5a**--**f** in moderate to good yields. The best yield (52%) was obtained with *p*-nitrobenzaldehyde (**4a**). Unexpectedly, *o,p*-bromobenzaldehyde (**4e**,**4b**) gave the same yield (49%), while *o*-nitrobenzaldehyde (**4d**) and *m*-bromobenzaldehyde (**4f**) gave approximately the same yield (44% and 43%, respectively). Notably, with *p*-nitrobenzaldehyde (**4a**) we observed 23% of the ester **6**. According to a recent mechanistic study \[[@B36-molecules-20-01262]\], the formation of the unexpected ester derivative **6** may be explained by an electron transfer in a primary step between 4-nitrobenzaldehyde (**4a**) as acceptor and TDAE as donor.

*p*-Cyanobenzaldehyde (**4c**) produced a moderate yield (31%). The formation of these alcohol derivatives may be explained by nucleophilic addition of benzazolinonic carbanions formed by the action of TDAE with 5-(bromomethyl)-3-methyl-6-nitrobenzoxazolone (**2**) on the carbonyl group of the corresponding aldehyde. In summary, the difference in yields does not appear to be totally explained by electronic effects: the halogen groups furnished approximately the same yields in either position. With nitrobenzaldehydes, steric hindrance could explain the difference between *o*- and *p*-nitrobenzaldehyde yields (44% *versus* 52%).

It is important to note that in the reactions of substrate **2** with the electrophiles **4b**--**f**, we observed the unavoidable formation of the reduction product **1** \[[@B37-molecules-20-01262]\]. Extending the reaction times to 8 h at ambient temperature increases its percentage, but decreases the yield of alcohol. On the other hand, after 4 h of reaction, the percentage of reduction product decreases at the same time as that of the alcohol: in this case we also observed traces of the dimerization of substrate **2**.

Moreover, after the reaction with aromatic aldehydes, we investigated the reaction of **2** with α-keto-ester derivatives such as ethyl glyoxylate (**4g**), diethyl ketomalonate (**4h**), acenaphtenedione (**4i**) and 1-methylisatin (**4j**) in the presence of TDAE. The reactions with these electrophiles furnished the corresponding hydroxyl derivatives **5i**--**j** in good yields (59%--63%), as shown in [Table 1](#molecules-20-01262-t001){ref-type="table"} and [Scheme 3](#molecules-20-01262-f003){ref-type="scheme"}.

![TDAE reactivity of the 5-(bromomethyl)-3-methyl-6-nitrobenzoxazolone (**2**) and α-diketone and α-ketolactam derivatives **4i**--**j**.](molecules-20-01262-g003){#molecules-20-01262-f003}

2.3. TDAE Reactivity of 5-(Dibromomethyl)-3-methyl-6-nitrobenzoxazolone (**3**)
-------------------------------------------------------------------------------

The optimized protocol of the dibromomethyl derivative **3**, was defined with 3 equivalents of aromatic carbonyls **4a**--**h**, 1 equivalent of 5-(dibromomethyl)-3-methyl-6-nitrobenzoxazolone (**3**) and 1.5 equivalents of TDAE in anhydrous DMF, for 1 h at −20 °C followed by 2 h at r.t. The reactions led to a mixture of *cis*/*trans* isomers of the corresponding oxiranes **7a**--**h** in moderate to good yields as reported in [Table 2](#molecules-20-01262-t002){ref-type="table"} ([Scheme 4](#molecules-20-01262-f004){ref-type="scheme"}). The formation of these oxiranes may be explained by nucleophilic addition of a α-bromocarbanion, formed by the action of TDAE with 5-(dibromomethyl)-3-methyl-6-nitrobenzoxazolone (**3**), on the carbonyl group of aldehydes **4a**--**h** followed by an intramolecular nucleophilic substitution \[[@B26-molecules-20-01262]\].

In the case of the nitroaromatic aldehydes, steric hindrance could explain the yield difference between *o*- and *p*-nitrobenzaldehyde (46% and 63%). However, this effect disappears in the *o*-bromo-substituted aldehyde which gave 64% of the corresponding oxirane, the *p*- and *m*- substituted aldehydes with 55 and 48% yields respectively. *p*-Cyanobenzaldehyde gave the expected oxirane in good yield (72%).

Under the same experimental conditions, we studied the reaction of derivative **3** with α-keto-ester derivatives **4g**--**h** as reported in [Table 2](#molecules-20-01262-t002){ref-type="table"} ([Scheme 4](#molecules-20-01262-f004){ref-type="scheme"}). Only the *trans* isomers of the oxiranes **7g** and **7h** were obtained in 26% and 37% yields, respectively, with ethyl glyoxylate (**4g**) and diethyl ketomalonate (**4h**). Otherwise, acenaphtenedione (**4i**) and methyl isatin (**4j**) furnished mixtures of *like*/*unlike* original stereoisomers **7i** and **7j**, respectively, in good yields ([Scheme 5](#molecules-20-01262-f005){ref-type="scheme"}). The diastereoisomers were separable, and their configuration was identified by NMR-analysis from the γ-left effect, as previously described \[[@B26-molecules-20-01262],[@B38-molecules-20-01262]\].

molecules-20-01262-t002_Table 2

###### 

Reaction of dibromide **3** with aromatic carbonyl and α-carbonyl ester derivatives using TDAE ^a^.

  Entry ^a^   Aromatic Carbonyl      *R*~1~             *R*~2~          Oxirane   Cis/Trans Isomers % ^b^   Yield (%) ^c^
  ----------- ---------------------- ------------------ --------------- --------- ------------------------- ---------------
  **1**       4-Nitrobenzaldehyde    4-NO~2~-C~6~H~4~   H               **7a**    15/85                     63
  **2**       4-Bromobenzaldehyde    4-Br-C~6~H~4~      H               **7b**    7/93                      55
  **3**       4-Cyanobenzaldehyde    4-CN-C~6~H~4~      H               **7c**    15/85                     72
  **4**       2-Nitrobenzaldehyde    2-NO~2~-C~6~H~4~   H               **7d**    32/68                     46
  **5**       2-Bromobenzaldehyde    2-Br-C~6~H~4~      H               **7e**    19/81                     64
  **6**       3-Bromobenzaldehyde    3-Br-C~6~H~4~      H               **7f**    7/93                      48
  **7**       Ethyl glyoxylate       CO~2~C~2~H~5~      H               **7g**    0/100                     26
  **8**       Diethyl ketomalonate   CO~2~C~2~H~5~      CO~2~C~2~H~5~   **7h**    0/100                     37

Notes: ^a^ All the reactions were performed using 3 equivalents of aromatic carbonyl **4a**--**h**, 1 equivalent of dibromide **3** and 1.5 equivalent of TDAE in anhydrous DMF stirred at −20 °C for 1 h and then warmed to r.t for 2 h; ^b^ % isomers determined on ^1^H-NMR measurements from the crude product; ^c^ % yield relative to dibromide **3**.

![TDAE reactivity of 5-(dibromomethyl)-3-methyl-6-nitrobenzoxazolone (**3**) with aromatic carbonyl and some α-keto-ester derivatives **4a**--**h**.](molecules-20-01262-g004){#molecules-20-01262-f004}

![TDAE reactivity of 5-(dibromomethyl)-3-methyl-6-nitrobenzoxazolone (**3**) and α-keto-ester derivatives **4i**--**j**.](molecules-20-01262-g005){#molecules-20-01262-f005}

The relative *cis*/*trans* percentages of oxirane isomers reported in [Table 2](#molecules-20-01262-t002){ref-type="table"} showed that the stereoselectivity of these reactions is not only sensitive to steric hindrance, but it also depends on the nature of the electrophile substituents. The reactions with bromo-substituted aldehydes in either position were more selective than with nitro-substituted aldehydes. The same percentages of *cis*/*trans* isomers were previously reported with *p*-nitro- and cyanobenzaldehyde. However, the reactions with ethyl glyoxylate and diethyl ketomalonate were the most selective. Moreover, stereoselectivity was recorded in the mixtures of *like*/*unlike* original stereoisomers with methyl isatin and acenaphtenedione.

3. Experimental Section
=======================

3.1. General Information
------------------------

Melting points were determined on a Buchi capillary melting point apparatus and are uncorrected. Elemental analyses were performed by the Centre de Microanalyses of the University of Aix-Marseille. Both ^1^H- (200 MHz) and ^13^C-NMR (50 MHz) spectra were determined on a Bruker AC 200 spectrometer. The ^1^H chemical shifts are reported as parts per million downfield from tetramethylsilane (Me~4~Si), and the ^13^C chemical shifts were referenced to the solvent peaks: CDCl~3~ (76.9 ppm) or Me~2~SO-*d*~6~ (39.6 ppm). Absorptions are reported using the following notation: s, singlet; d, doublet; t, triplet; q, quartet; m, a more complex multiplet or overlapping multiplets. The following adsorbents were used for column chromatography: silica gel 60 (Merck, Darmstadt, Germany, particle size 0.063--0.200 mm, 70--230 mesh ASTM). TLC was performed on 5 cm × 10 cm aluminium plates coated with silica gel 60 F-254 (Merck) in an appropriate solvent. 3,5-Dimethyl-6-nitrobenzoxazolone (**1**) was synthesized in three steps: condensation of 2-amino-4-methylphenol with urea \[[@B34-molecules-20-01262]\], methylation using dimethyl sulfate and nitration by action of a mixture of nitric and sulfuric acids.

3.2. Synthesis of Substrates **1**--**3**
-----------------------------------------

*3,5-Dimethyl-6-nitrobenzo\[d\]oxazol-2(3H)-one* (**1**): yellow solid; mp 159 °C (EtOH); ^1^H-NMR (CDCl~3~): δ 2.70 (s, 3H, CH~3~), 3.45 (s, 3H, NCH~3~), 6.87 (s, 1H, CH), 7.95 (s, 1H, CH). ^13^C-NMR (CDCl~3~): δ 21.6 (CH~3~), 28.5 (NCH~3~), 107.3 (CH), 110.7 (CH), 132.2 (C), 135.7 (C), 140.2 (C), 143.5 (CNO~2~), 154.3 (CO). Anal. Calcld. for C~9~H~8~N~2~O~4~ (208.17): C, 51.93; H, 3.87; N; 13.46. Found: C, 52.34; H, 3.95; N, 13.40.

5-(Bromomethyl)-3-methyl-6-nitrobenzo\[*d*\]oxazol-2(3*H*)-one (**2**) and 5-(dibromomethyl)-3-methyl-6-nitrobenzo\[*d*\]oxazol-2(3*H*)-one (**3**) were prepared according to a previously described method \[[@B27-molecules-20-01262]\].

*5-(Bromomethyl)-3-methyl-6-nitrobenzo\[d\]oxazol-2(3H)-one* (**2**): yellow solid (EtOH); mp 120 °C; ^1^H-NMR (CDCl~3~): δ 3.49 (s, 3H, CH~3~), 4.91 (s, 2H, CH~2~Br), 7.14 (s, 1H, CH), 7.99 (s, 1H, CH). ^13^C-NMR (CDCl~3~): δ 28.7 (NCH~3~), 29.3 (CH~2~Br), 108.0 (CH), 110.6 (CH), 131.1 (C), 136.1 (C), 141.7 (C), 142.6 (CNO~2~), 153.9 (CO). Anal. Calcld for C~9~H~7~BrN~2~O~4~ (287.07): C, 37.66; H, 2.46; N; 9.76. Found: C, 38.48; H, 2.58; N, 9.88.

*5-(Dibromomethyl)-3-methyl-6-nitrobenzo\[d\]oxazol-2(3H)-one* (**3**): yellow solid (EtOH); mp 134 °C; ^1^H-NMR (CDCl~3~): δ 3.55 (s, 3H, NCH~3~), 7.55 (s, 1H, CHBr~2~), 7.75 (s, 1H, CH), 7.78 (s, 1H, CH). ^13^C-NMR (CDCl~3~): δ 29.0 (NCH~3~), 34.4 (CHBr~2~), 106.2 (CH), 110.7 (CH), 134.3 (C), 136.5 (C), 139.0 (C), 142.0 (CNO~2~), 153.6 (CO). Anal. Calcld for C~9~H~7~BrN~2~O~4~ (365.96): C, 29.54; H, 1.65; N; 7.65. Found: C, 29.59; H, 1.67; N, 7.69.

3.3. General Procedure for the Reaction of **2** and Aromatic Carbonyl Derivatives **4a**--**f**, α-Carbonyl Ester **4g**, Ketomalonate **4h**, Acenaphtenedione **4i** and Ketolactam **4j** Using TDAE
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

A solution of **2** (0.5,1.74 mmol) in anhydrous DMF (10 mL) and the corresponding carbonyl derivative **4a**--**j** (5.22 mmol, 3 equivalents) were placed under nitrogen at −20 °C in a two-necked flask equipped with a silica-gel drying tube and a nitrogen inlet. The solution was stirred and maintained at this temperature for 30 min and then the TDAE (0.41 mL, 1.74 mmol, 1 equivalent) was added dropwise via a syringe. A red color immediately developed with the formation of a fine white precipitate. The solution was vigorously stirred at −20 °C for 1 h and then warmed to r.t. for 2 h. After this time TLC analysis (dichloromethane) clearly showed that **2** was totally consumed. The orange-red turbid solution was filtered (to remove the octamethyloxamidinium dibromide) and hydrolyzed with 80 mL of H~2~O. The aqueous solution was extracted with toluene (3 × 40 mL), the combined organic layers washed with H~2~O (3 × 40 mL) and dried over MgSO~4~. Evaporation of the solvent left an orange viscous liquid as crude product. Purification by silica gel chromatography and recrystallization in ethyl alcohol gave the corresponding products.

*5-(2-Hydroxy-2-(4-nitrophenyl)ethyl)-3-methyl-6-nitrobenzo\[d\]oxazol-2(3H)-one* (**5a**): Brown solid; mp 233 °C; ^1^H-NMR (DMSO-*d*~6~): δ 3.37 (s, 3H, NCH~3~), 3.17--3.33 (m, 2H, 2 × CH), 4.92--5.01 (m, 1H, 1H, CH), 5.67 (bs, 1H, OH), 7.33 (s, 1H, CH), 7.61 (d, *J* = 8,5 Hz, 2H, 2 × CH), 8.00 (s, 1H, CH), 8.21 (d, *J* = 8.5 Hz, 2H, 2 × CH). ^13^C-NMR (DMSO-*d*~6~): δ 28.9 (NCH~3~), 42.2 (CH~2~), 72.1 (CH), 106.7 (CH), 112.5 (CH), 123.6 (2 × CH), 127.0 (2 × CH), 131.2 (C), 135.8 (C), 140.2 (C), 144.1 (C), 146.7 (C), 153.2 (C), 154.3 (CO). HRMS (EI): calcd for C~16~H~13~N~3~O~7~ (M^+^) 337.1092, found 337.1092.

*5-(2-(4-Bromophenyl)-2-hydroxyethyl)-3-methyl-6-nitrobenzo\[d\]oxazol-2(3H)-one* (**5b**): Brown solid; mp 213 °C; ^1^H-NMR (CDCl~3~): δ 2.13 (d, *J* = 3.2 Hz, 1H, OH), 3.13 (dd, *J* = 13.7 Hz, *J* = 9.1 Hz, 1H, CH), 3.43 (s, 3H, NCH~3~), 3.50 (dd, *J* = 13.7 Hz, *J* = 3.7 Hz, 1H, CH), 5.06 (dd, *J* = 9.1 Hz, *J* = 3.7 Hz, 1H, CH), 6.85 (s, 1H, CH), 7.33 (d, *J* = 8.4 Hz, 2H, 2 × CH), 7.52 (d, *J* = 8.4 Hz, 2H, 2 × CH), 7.94 (s, 1H, CH). ^13^C-NMR (CDCl~3~): δ 28.6 (NCH~3~), 43.7 (CH~2~), 73.5 (CH), 107.5 (CH), 111.9 (CH), 121.7 (C), 127.3 (2 × CH), 131.7 (2 × CH), 135.6 (C), 140.8 (C), 142.7 (CH), 144.0 (C), 154.3 (CO). C-NO~2~ was not observed under these experimental conditions. Anal. Calcld for C~16~H~13~BrN~2~O~5~ (393.19) C, 48.88; H, 3.33; N; 7.12. Found: C, 48.91; H, 3.39; N, 7.19.

*4-(1-Hydroxy-2-(3-methyl-6-nitro-2-oxo-2,3-dihydrobenzo\[d\]oxazol-5-yl)ethyl)benzonitrile* (**5c**): Yellow solid; mp 213 °C; ^1^H-NMR (CDCl~3~): δ 2.27 (d, *J* = 3.0 Hz, 1H, OH), 3.05 (dd, *J* = 13.5 Hz, *J* = 9.4 Hz, 1H, CH), 3.46 (s, 3H, NCH~3~), 3.57 (dd, *J* = 13.5 Hz, *J* = 2.6 Hz, 1H, CH), 5,15 (dd, *J* = 9.4 Hz, *J* = 2.6 HZ, 1H, CH), 6.93 (s, 1H, CH), 7.61 (d, *J* = 8.3 Hz, 2H, 2 × CH), 7.70 (d, *J* = 8.3 Hz, 2H, 2 × CH); 7.98 (s,1H, CH). ^13^C-NMR (CDCl~3~): δ 28.6 (NCH~3~), 43.8 (CH~2~), 73.3 (CH), 107.6 (CH), 111.7 (C), 112.0 (CH), 118.7 (C), 126.3 (2 × CH), 131.5 (C), 132.5 (2 × CH), 135.7 (C), 140.9 (C), 149.0 (C), 154.2 (CO). C-NO~2~ was not observed under these experimental conditions. HRMS (EI): calcd for C~17~H~13~N~3~O~5~ (M^+^) 357.1193, found 357.1194.

*5-(2-Hydroxy-2-(2-nitrophenyl)ethyl)-3-methyl-6-nitrobenzo\[d\]oxazol-2(3H)-one* (**5d**): Brown solid; mp 130 °C; ^1^H-NMR (CDCl~3~): δ 3.36 (dd, *J* = 13.8 Hz, *J* = 8.8 Hz, 1H, CH), 3.41 (s, 3H, NCH~3~), 3.56 (dd, *J* = 13.8 Hz, *J* = 3.2 Hz, 1H, CH), 5.47 (dd, *J* = 8.8 Hz, *J* = 3.2 Hz, 1H, CH), 7.05 (s, 1H, CH), 7.44 (t, *J* = 7.0 Hz, 1H, CH), 7.65 (t, *J* = 7.6 Hz, 1H, CH), 7.73 (s, 1H, CH), 7.80 (d, *J* = 7.0 Hz, 1H, CH), 7.89 (d, *J* = 7.6 Hz, 1H, CH). ^13^C-NMR (CDCl~3~): δ 28.5 (NCH~3~), 40.6 (CH~2~), 70.4 (CH), 107.1 (CH), 111.0 (CH), 124.5 (CH), 128.4 (CH), 128.6 (CH), 131.1 (C), 133.9 (CH), 135.5 (C), 139.1 (C), 140.5 (C), 144.8 (C), 147.4 (C), 154.3 (CO). HRMS (EI): calcd for C~16~H~13~N~3~O~7~ (M^+^) 337.1092, found 337.1092.

*5-(2-(2-Bromophenyl)-2-hydroxyethyl)-3-methyl-6-nitrobenzo\[d\]oxazol-2(3H)-one* (**5e**): Yellow solid; mp 159 °C; ^1^H-NMR (DMSO-*d*~6~): δ 3.29 (s, 3H, NCH~3~), 3.30--3.33 (m, 2H, CH~2~), 5.51 (bs, 1H, CH), 7.15 (s, 1H, CH), 7.21 (d, *J* = 7.3 Hz, 1H, CH), 7.40 (t, *J* = 7.7 Hz, 1H, CH), 7.51--7.54 (m, 2H, 2 × CH), 7.95 (s, 1H, CH). ^13^C-NMR (DMSO-*d*~6~): δ 28.6 (NCH~3~), 40.5 (CH~2~), 71.35 (CH), 106.6 (CH), 111.9 (CH), 121.4 (C), 128.1 (CH), 128.3 (CH), 129.3 (C), 130.5 (CH), 132.3 (CH), 135.4 (C), 140.1 (C), 143.8 (C), 144.7 (C), 154.3 (CO). HRMS (EI): calcd for C~16~H~13~BrN~2~O~5~ (M^+^) 410.0346, found 410.0347.

*5-(2-(3-Bromophenyl)-2-hydroxyethyl)-3-methyl-6-nitrobenzo\[d\]oxazol-2(3H)-one* (**5f**): Yellow solid; mp 154 °C; ^1^H-NMR (CDCl~3~): δ 2.15 (d, *J* = 2.9 Hz, 1H, OH), 3.13 (dd, *J* = 13.6 Hz, *J* = 9.0 Hz, 1H, CH), 3.44 (s, 3H, NCH~3~), 3.53 (dd, *J* = 13.6 Hz, *J* = 3.4 Hz, 1H, CH), 5.08 (dd, *J* = 9.0 Hz, *J* = 3.4 Hz, 1H, CH), 6.87 (s, 1H, CH), 7.29 (s, 1H, CH), 7.35--7.48 (m, 2H, 2 × CH), 7.61--7.63 (m, 1H, CH), 7.95 (s,1H, CH). ^13^C-NMR (CDCl~3~): δ 28.5 (NCH~3~), 43.7 (CH~2~), 73.4 (CH), 107.5 (CH), 111.9 (CH), 122.8 (C), 124.3 (CH), 128.7 (CH), 130.2 (CH), 131.0 (CH), 131.7 (C), 135.6 (C), 140.8 (C), 144.0 (C), 146.1 (C), 154.3 (CO). Anal. Calcld for C~16~H~13~BrN~2~O~5~ (393.19) C, 48.88; H, 3.33; N, 7.12. Found: C, 49.11; H, 3.46; N, 7.28.

*Ethyl 2-hydroxy-3-(3-methyl-6-nitro-2-oxo-2,3-dihydrobenzo\[d\]oxazol-5-yl)propanoate* (**5g**): Yellow solid; mp 136 °C; ^1^H-NMR (CDCl~3~): δ 1.32 (t, *J* = 7.1 Hz, 3H, CH~3~), 2.99 (d, *J* = 5.3 Hz, 1H, OH), 3.17 (dd, *J* = 13.9 Hz, *J* = 8.8 Hz, 1H, CH), 3.46 (s, 3H, NCH~3~), 3.68 (dd, *J* = 13.9 Hz, *J* = 3.7 Hz, 1H, CH), 4.28 (q, *J* = 7.1 Hz 2H, CH~2~), 4.50--4.55 (m, 1H, CH), 7.02 (s, 1H, CH), 7.91 (s, 1H, CH). ^13^C-NMR (CDCl~3~): δ 14.1 (CH~3~), 28.6 (NCH~3~), 37.9 (CH~2~), 62.4 (CH~2~), 70.1 (CH), 107.4 (CH), 111.6 (CH), 130.3 (CH), 135.5 (CH), 140.8 (CH), 144.2 (CH), 154.2 (CO), 173.9 (CO). Anal. Calcld for C~13~H~14~N~2~O~7~ (310.26) C, 50.33; H, 4.55; N, 9.03. Found: C, 50.28; H, 4.54; N, 8.91

*Diethyl 2-hydroxy-2-((3-methyl-6-nitro-2-oxo-2,3-dihydrobenzo\[d\]oxazol-5-yl)methyl)malonate* (**5h**): Yellow solid; mp 111 °C; ^1^H-NMR (CDCl~3~): δ 1.27 (t, *J* = 7.1 Hz, 6H, 2xCH~3~), 3.43 (s, 3H, NCH~3~), 3.85 (bs, 1H, OH), 3.88 (s, 2H, CH~2~), 4.11--4.34 (m, 4H, CH~2~), 7.14 (s, 1H, CH), 7.75 (s, 1H, CH). ^13^C-NMR (CDCl~3~): δ 13.9 (2 × CH~3~), 28.5 (NCH~3~), 35.5 (2 × CH~2~), 63.1 (CH~2~), 78.4 (C-OH), 107.2 (CH), 111.8 (CH), 127.1 (C), 134.8 (C), 140.8 (C), 145.6 (C), 154.2 (CO), 169.4 (2 × CO). Anal. Calcld for C~16~H~18~N~2~O~9~ (382.32) C, 50.26, H, 4.75, N, 7.33. Found: C, 50.25, H, 4.83, N, 7.18.

*5-((1-Hydroxy-2-oxo-1,2-dihydroacenaphthylen-1-yl)methyl)-3-methyl-6-nitrobenzo\[d\]oxazol-2(3H)-one* (**5i**): Green solid; mp 204 °C; ^1^H-NMR (CDCl~3~): δ 3.45 (s, 3H, NCH~3~), 3.64 (d, *J* = 14.0 Hz, 1H, CH), 3.84 (d, *J* = 14.0 Hz, 1H, CH), 7.12 (s, 1H, CH), 7.27 (d, *J* = 7.3 Hz, 1H, CH), 7.61 (dd, *J* = 8.0 Hz, *J* = 7.3 Hz,1H, CH), 7.77 (dd, *J* = 7.8 Hz, *J* = 7.3 Hz, 1H, CH), 7.88 (s, 1H, CH), 7.89--7.98 (m, 2H, 2 × CH), 8.15 (d, *J* = 8.0 Hz, 1H, CH). ^13^C-NMR (CDCl~3~): δ 28.6 (NCH~3~), 40.9 (CH~2~), 79.8 (C-OH), 107.5 (CH), 112.4 (CH), 120.3 (CH), 122.7 (CH), 125.9 (CH), 128.6 (CH), 128.7 (CH+C), 130.1 (C), 130.7 (C), 132.4 (CH), 135.3 (C), 138.7 (C), 140.7 (C), 141.0 (C), 144.5 (C), 154.3 (CO); 203.8 (CO). Anal. Calcld for C~21~H~14~N~2~O~6~ (390.35) C, 64.62, H, 3.62, N, 7.18. Found: C, 64.15, H, 3.72, N, 7.05.

*5-((3-Hydroxy-1-methyl-2-oxoindolin-3-yl)methyl)-3-methyl-6-nitrobenzo\[d\]oxazol-2(3H)-one* (**5j**): Yellow solid; mp 253 °C; ^1^H-NMR (DMSO-*d*~6~): δ 3.03 (s, 3H, NCH~3~), 3.31 (s, 3H, NCH~3~), 3.36 (d, *J* = 13.7 Hz, 1H, CH), 3.66 (d, *J* = 13.7 Hz, 1H, CH), 6.19 (s, 1H, CH), 6.78 (d, *J* = 6.8 Hz, 1H, CH), 6.91--6.95 (m, 2H, 2 × CH), 7.13 (s, 1H, CH), 7.24--7.31 (m, 1H, CH). ^13^C-NMR (DMSO-*d*~6~): δ 26.0 (NCH~3~); 28.5 (NCH~3~), 75.4 (C-OH), 106.7 (CH), 108.6 (CH), 112.9 (CH), 122.3 (CH), 123.9 (CH), 127.6 (C), 129.4 (CH), 130.5 (C), 135.0 (C), 140.3 (C), 142.8 (C), 144.7 (C), 154.3 (CO), 176.8 (CO). C-NO~2~ was not observed under these experimental conditions. Anal. Calcld for C~18~H~15~N~3~O~6~ (369.33) C, 58.54, H, 4.09, N, 11.38. Found: C, 58.26, H, 4.25, N, 11.01.

*1-(3-Methyl-6-nitro-2-oxo-2,3-dihydrobenzo\[d\]oxazol-5-yl)-2-(4-nitrophenyl)ethyl 4-nitrobenzoate* (**6**): Yellow solid; mp 305 °C; ^1^H-NMR (CDCl~3~): δ 3.35 (s, 3H, NCH~3~), 3.73 (d, *J* = 6.2 Hz, 2H, CH~2~), 6.44 (t, *J* = 6.2 Hz, 1H, CH), 6.84 (s, 1H, CH), 7.68 (d, *J* = 8.5 Hz, 2H, 2 × CH), 7.97 (s, 1H, CH), 8.17 (d, *J* = 8.8 Hz, 2H, 2 × CH), 8.28 (d, *J* = 8.5 Hz, 1H, 2 × CH), 8.32 (d, *J* = 8.5 Hz, 1H, 2 × CH). ^13^C-NMR (CDCl~3~): δ 28.5 (NCH~3~), 40.8 (CH~2~), 76.4 (CH), 108.1 (CH), 110.7 (CH), 114.1 (C), 123.8 (2 × CH), 124.3 (2 × CH), 127.1 (2 × CH), 129.6 (C), 130.7 (2 × CH), 134.4 (C), 135.9 (C), 141.2 (C), 145.9 (C), 148.1 (C), 150.9 (C), 153.8 (CO). HRMS (EI): calcd for C~23~H~16~N~4~O~10~ (M^+^) 526.1205, found 526.1209.

3.4. General Procedure for the Reaction of **3** and Aromatic Carbonyl Derivatives **4a**--**f**, α-Carbonyl Ester **4g**, Ketomalonate **4h**, Acenaphtenedione **4i** and Keto-lactam **4j** Using TDAE
---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

A solution of **3** (0.5 g, 1.36 mmol) in anhydrous DMF (10 mL) and the corresponding carbonyl derivative **4a**--**j** (4.098 mmol, 3 equivalents) were placed under nitrogen at −20 °C in a two-necked flask equipped with a silica-gel drying tube and a nitrogen inlet. The solution was stirred and maintained at this temperature for 30 min and then the TDAE (0.48 mL, 2.049 mmol, 1.5 equivalent) was added dropwise via a syringe. A red color immediately developed with the formation of a fine white precipitate. The solution was vigorously stirred at −20 °C for 1 h and then warmed to rt for 2 h. After this time TLC analysis (dichloromethane) clearly showed that **3** was totally consumed. The orange-red turbid solution was filtered (to remove the octamethyloxamidinium dibromide) and hydrolyzed with 80 mL of H~2~O. The aqueous solution was extracted with toluene (3 × 40 mL), the combined organic layers washed with H~2~O (3 × 40 mL) and dried over MgSO~4~. Evaporation of the solvent left an orange viscous liquid as crude product. Purification by silica gel chromatography and recrystallization in ethyl alcohol solvent gave the corresponding oxiranes **7a**--**j**.

*3-Methyl-6-nitro-5-(3-(4-nitrophenyl)oxiran-2-yl)benzo\[d\]oxazol-2(3H)-one* (**7a**) *trans*-isomer: Yellow solid; mp 224 °C; ^1^H-NMR (CDCl~3~): δ 3.52 (s, 3H, NCH~3~), 3.92 (d, *J* = 1.9 Hz, 1H, CH), 4.54 (d, *J* = 1.9 Hz, 1H, CH), 7.33 (s, H, CH), 7.60 (d, *J* = 8.7 Hz, 2H, 2 × CH), 8.13 (s, 1H, CH), 8.30 (d, *J* = 8.7 Hz, 2H, 2 × CH). ^13^C-NMR (CDCl~3~): δ 28.8 (NCH~3~), 61.0 (CH), 61.1 (CH), 105.7 (CH), 107.4 (CH), 124.0 (2 × CH), 126.6 (2 × CH), 131.8 (C), 137.28 (C), 141.6 (C), 142.1 (C), 143.0 (C), 148.2 (CO). C-NO~2~ was not observed under these experimental conditions. HRMS (EI): calcd for C~16~H~11~N~3~O~7~ (M^+^) 375.0935, found 375.0943.

*5-(3-(4-Bromophenyl)oxiran-2-yl)-3-methyl-6-nitrobenzo\[d\]oxazol-2(3H)-*one (**7b**) *trans*-isomer: Yellow solid; mp 209 °C; ^1^H-NMR (CDCl~3~): δ 3.51 (s, 3H, NCH~3~), 3.77 (d, *J* = 1.9 Hz, 1H, CH), 3.54 (d, *J* = 1.9 Hz, 1H, CH), 7.28 (d, *J* = 8.4 Hz, 2H, 2 × CH), 7.31 (s, 1H, CH), 7.54 (d, *J* = 8.4 Hz, 2H, 2 × CH), 8.11 (s, 1H, CH). ^13^C-NMR (CDCl~3~): δ 28.7 (NCH~3~), 60.5 (CH), 61.7 (CH), 105.6 (CH), 107.3 (CH), 122.8 (C), 127.5 (2 × CH), 131.9 (2 × CH), 132.5 (C), 134.8 (C), 137.0 (C), 141.3 (C), 154.1 (CO). Anal. Calcld for C~16~H~11~BrN~2~O~5~ (391.17) C, 49.13; H, 2.83; N, 7.16. Found: C, 49.27; H, 2.92; N, 7.85.

*4-(3-(3-Methyl-6-nitro-2-oxo-2,3-dihydrobenzo\[d\]oxazol-5-yl)oxiran-2-yl)*benzonitrile (**7c**) *trans*-isomer: Yellow solid; mp 213 °C; ^1^H-NMR (CDCl~3~): δ 3.51 (s, 3H, NCH~3~), 3.86 (d, *J* = 1.8 Hz, H, CH), 4.52 (d, *J* = 1.8 Hz, H, CH), 7.32 (s, 1H, CH), 7.53 (d, *J* = 8.3 Hz, 2H, 2 × CH), 7.72 (d, *J* = 8.3 Hz, 2H, 2 × CH), 8.12 (s, 1H, CH). ^13^C-NMR (CDCl~3~): δ 28.7(NCH~3~), 61.0 (CH), 61.2 (CH), 105.7 (CH), 107.3 (CH), 112.6 (C), 118.5 (C), 126.5 (2 × CH), 131.9 (C), 132.5 (2 × CH), 137.1(C), 141.1 (C), 141.5 (C), 142.1(C); 154.1 (CO). HRMS (EI): calcd for C~17~H~11~N~3~O~5~ (M^+^) 355.1037, found 355.1036.

*3-Methyl-6-nitro-5-(3-(2-nitrophenyl)oxiran-2-yl)benzo\[d\]oxazol-2(3H)-*one (**7d**) *trans*-isomer: yellow solid; mp 215 °C; ^1^H-NMR (CDCl~3~): δ 3.52 (s, 3H, NCH~3~), 4.54 (d, *J* = 2.0 Hz, 1H, CH), 4.60 (d, *J* = 2.0 Hz, 1H, CH), 7.36 (s, 1H, CH), 7.52--7.61 (m, 1H, CH), 7.75--7.77 (m, 2H, 2 × CH), 8.14 (s, 1H, CH), 8.23 (d, *J* = 8.0 Hz, 1H, CH). ^13^C-NMR (CDCl~3~): δ 28.7 (NCH~3~), 59.9 (CH), 60.0 (CH), 105.5 (CH), 107.6 (CH), 125.2 (CH), 126.9 (CH), 129.2 (C), 131.8 (CH), 132.5 (C), 134.4 (CH), 137.0 (C), 141.5 (C), 142.6 (C), 147.9 (C), 154.2 (CO). HRMS (EI): calcd for C~16~H~11~N~3~O~7~ (M^+^) 375.0935, found 375.0940.

*3-Methyl-6-nitro-5-(3-(2-nitrophenyl)oxiran-2-yl)benzo\[d\]oxazol-2(3H)-one* (**7d**) *cis*-isomer: Beige solid; mp 166 °C; ^1^H-NMR (CDCl~3~): δ 3.38 (s, 3H, NCH~3~), 5.14 (d, *J* = 4.9 Hz, 1H, CH), 5.17 (d, *J* = 4.9 Hz, 1H, CH), 7.03 (s, 1H, CH), 7.30--7.40 (m, 1H, CH), 7.44--7.46 (m, 2H, 2 × CH), 7.86--7.90 (m, 2H, 2 × CH). ^13^C-NMR (CDCl~3~): δ 28.6 (NCH~3~), 59.0 (2 × CH), 107.3 (CH), 107.4 (CH), 124.7 (CH), 128.8 (CH), 128.9 (C), 129.2 (CH), 129.4 (C), 132.7 (CH), 135.9 (C), 141.2 (C), 148.5 (C), 153.9 (CO). Anal. Calcld for C~16~H~11~N~3~O~7~ (357.27) C, 53.79; H, 3.10; N, 11.76. Found: C, 53.48; H, 3.30; N, 11.44.

*5-(3-(2-Bromophenyl)oxiran-2-yl)-3-methyl-6-nitrobenzo\[d\]oxazol-2(3H)-one* (**7e**) *trans*-isomer: Green solid; mp 203 °C; ^1^H-NMR (CDCl~3~): δ 3.52 (s, 3H, NCH~3~), 4.09 (d, *J* = 1.9 Hz, 1H, CH), 4.57 (d, *J* = 1.9 Hz, 1H, CH), 7.20--7.29 (m, 1H, CH), 7.36 (s, 1H, CH), 7.38--7.47 (m, 2H, 2 × CH), 7.60 (d, *J* = 7.5 Hz, 1H, CH), 8.12 (s, 1H, CH). ^13^C-NMR (CDCl~3~): δ 28.7 (NCH~3~), 60.1 (CH), 62.0 (CH), 105.6 (CH), 107.4 (CH), 123.1 (C), 126.1 (CH), 127.8 (CH), 130.0 (CH), 132.2 (C), 132.7 (CH), 135.2 (C), 137.0 (C), 141.4 (C), 142.4 (C), 154.2 (CO). Anal. Calcld for C~16~H~11~BrN~2~O~5~ (391.17) C, 49.13; H, 2.83; N, 7.16. Found: C, 49.27; H, 2.93; N, 7.17.

*5-(3-(2-Bromophenyl)oxiran-2-yl)-3-methyl-6-nitrobenzo\[d\]oxazol-2(3H)-one* (**7e**) *cis*-isomer: Green solid; mp 151 °C; ^1^H-NMR (CDCl~3~): δ 3.42 (s, 3H, NCH~3~), 4.71 (d, *J* = 4.4 Hz, 1H, CH), 5.17 (d, *J* = 4.4 Hz, 1H, CH), 6.98--7.14 (m, 3H, 3 × CH), 7.16 (s, 1H, CH), 7.36--7.42 (m, 1H, CH), 7.93 (s, 1H, CH). ^13^C-NMR (CDCl~3~): δ 28.6 (NCH~3~), 59.3 (CH), 61.0 (CH), 107.3 (CH), 107.9 (CH), 122.5 (C), 126.4 (CH), 128.0 (CH), 129.4 (C), 129.6 (CH), 132.7 (CH), 132.9 (C), 135.8 (C), 141.1 (C), 142.5 (C), 154.0 (CO). Anal. Calcld for C~16~H~11~BrN~2~O~5~ (391.17) C, 49.13; H, 2.83; N, 7.16. Found: C, 49.42; H, 3.02; N, 7.28.

*5-(3-(3-Bromophenyl)oxiran-2-yl)-3-methyl-6-nitrobenzo\[d\]oxazol-2(3H)-one* (**7f**) *trans*-isomer: Beige solid; mp 165 °C; ^1^H-NMR (CDCl~3~): δ 3.51 (s, 3H, 3H, NCH~3~), 3.77 (d, *J* = 1.9 Hz, 1H, CH), 4.55 (d, *J* = 1.9 Hz, 1H, CH), 7.24--7.28 (m, 1H, CH), 7.32 (s, 1H, CH), 7.33--7.38 (m, 1H, CH), 7.49--7.54 (m, 2H, 2 × CH), 8.11 (s, 1H, CH). ^13^C-NMR (CDCl3): δ 28.7 (NCH~3~), 60.6 (CH), 61.4 (CH), 105.7 (CH), 107.3 (CH), 122.8 (C), 124.6 (CH), 128.7 (CH), 130.2 (CH), 131.9 (CH), 132.3 (C), 137.0 (C), 138.1 (C), 141.4 (C), 142.1 (C), 154.1 (CO). Anal. Calcld for C~16~H~11~BrN~2~O~5~ (391.17) C, 49.13; H, 2.83; N, 7.16. Found: C, 49.30; H, 2.97; N, 7.10.

*Ethyl 3-(3-methyl-6-nitro-2-oxo-2,3-dihydrobenzo\[d\]oxazol-5-yl)oxirane-2-carboxylate* (**7g**) *trans*-isomer: Light yellow needles; mp 199 °C; ^1^H-NMR (CDCl~3~): δ 1.36 (t, *J* = 7.2 Hz, H, CH); 3.38 (d, *J* = 1.9 Hz, 3H, CH); 3.48 (s, 3H, NCH~3~); 4,35 (q, *J* = 7.2 Hz, 2H, CH~2~); 4,75 (d, *J* = 1.9 Hz, 1H, CH); 7.19 (s, 1H, CH); 8.12 (s, 1H, CH). ^13^C-NMR (CDCl~3~): δ 14.1 (CH~3~), 28.8 (NCH~3~), 56.0 (CH), 56.6 (CH), 62.2 (CH~2~), 105.8 (CH), 107.4 (CH), 130.9 (C), 137.0 (C), 141.6 (C), 142.2 (C), 154.0 (CO), 167.2 (CO). HRMS (EI): calcd for C~13~H~12~N~2~O~7~ (M^+^) 309.0717, found 309.0713.

*Diethyl 3-(3-methyl-6-nitro-2-oxo-2,3-dihydrobenzo\[d\]oxazol-5-yl)oxirane-2,2-dicarboxylate* (**7h**) *trans*-isomer: Dark brown; mp 118 °C; ^1^H-NMR (CDCl~3~): δ 0.98 (t, *J* = 7.2 Hz, 3H, CH~3~), 1.37 (t, *J* = 7.2 Hz, 3H, CH~3~), 3.48 (s, 3H, NCH~3~), 3.98 (q, *J* = 7.2 Hz, 2H, CH~2~), 4.39 (q, *J* = 7.2 Hz, 2H, CH~2~), 5.14 (s, 1H, CH), 7.24 (s, 1H, CH), 8.12 (s, 1H, CH). ^13^C-NMR (CDCl~3~): δ 13.8 (CH~3~), 14.0 (CH~3~), 28.9 (NCH~3~), 61.2 (CH), 62.2 (CH~2~), 63.3 (CH~2~), 107.2 (CH), 107.4 (CH), 127.9 (C), 136.7 (C), 141.9 (C), 142.3 (C), 153.9 (C), 163.3 (CO), 164.6 (CO). Anal. Calcld for C~16~H~16~N~2~O~9~ (380.31) C, 50.53; H, 4.24; N, 7.37. Found: C, 50.96; H, 4.54; N, 7.25.

*3-Methyl-6-nitro-5-(2-oxo-2H-spiro\[acenaphthylene-1,2\'-oxiran\]-3\'-yl)benzo\[d\]oxazol-2(3H)-one* (**7i**) *like*-isomer: Yellow solid; mp 235 °C; ^1^H-NMR (CDCl~3~): δ 3.59 (s, 3H, NCH~3~), 5.29 (s, 1H, CH), 7.62 (d, *J* = 6.8 Hz, 1H, CH~2~), 7.74 (s, 2H, 2 × CH); 7.77--7.80 (m, 1H, CH), 7.85 (d, *J* = 6.7 Hz, 1H, CH~2~), 8.01 (d, *J* = 8.4 Hz, 1H, CH~2~), 8.06 (s, 1H, CH), 8.19 (d, *J* = 8.1 Hz, 1H, CH). ^13^C-NMR (CDCl~3~): δ 28.9 (NCH~3~), 65.8 (CH), 67.1 (C), 106.8 (CH), 108.9 (CH), 118.9 (CH), 122.1 (CH), 126.5 (CH), 128.3 (CH), 128.7 (CH), 129.2 (C), 130.4 (C), 131.2 (C), 132.1 (C), 132.3 (CH), 136.5 (C), 141.4 (C), 141.7 (C), 142.5 (C), 154.2 (CO), 196.0 (CO). Anal. Calcld for C~21~H~12~N~2~O~6~ (388.33) C, 64.95; H, 3.11; N, 7.21. Found: C, 64.08; H, 3.26; N, 6.85.

*3-Methyl-6-nitro-5-(2-oxo-2H-spiro\[acenaphthylene-1,2\'-oxiran\]-3\'-yl)benzo\[d\]oxazol-2(3H)-one* (**7i**) *unlike*-isomer: Beige solid; mp 201 °C; ^1^H-NMR (CDCl~3~): δ 3.63 (s, 3H, NCH~3~), 5.30 (s, 1H, CH), 6.34 (d, *J* = 6.8 Hz, 1H, CH~2~), 7.32 (d, *J* = 6,7 Hz, 1H, CH), 7.67 (s, 1H, CH), 7.77--7.88 (m, 2H, 2 × CH), 8.07 (s, 1H, CH), 8.12 (d, *J* = 1.7 Hz,1H, CH), CH), 8.16 (d, *J* = 3.2 Hz,1H, CH). ^13^C-NMR (CDCl~3~): δ 29.0 (NCH~3~), 64.7 (CH), 66.5 (C); 107.3 (CH), 107.7 (CH), 119.1 (CH), 122.7 (CH), 126.8 (CH), 127.8 (CH), 128.5 (CH), 129.7 (C), 130.2 (C), 130.5 (C), 130.6 (C), 132.3 (CH), 136.9 (C), 141.9 (C), 143.2 (C), 154.0 (C), 196.3 (CO). C-NO~2~ was not observed under these experimental conditions. HRMS (EI): calcd for C~21~H~12~N~2~O~6~ (M^+^) 389.0768, found 389.0768.

*1-Methyl-3\'-(3-methyl-6-nitro-2-oxo-2,3-dihydrobenzo\[d\]oxazol-5-yl)spiro\[indoline-3,2\'-oxiran\]-2-one* (**7j**) *like*-isomer: Beige solid; mp 190 °C; ^1^H-NMR (CDCl~3~): δ 3.13 (s, 3H, NCH~3~), 3.54 (s, 3H, NCH~3~), 5.15 (s, 1H, CH), 6.93 (dd, *J* = 7.8 Hz, *J* = 0.7 Hz,1H, CH), 7.17 (td, *J* = 7.5 Hz, *J* = 0.7 Hz,1H, CH), 7.32 (dd, *J* = 7.3 Hz, *J* = 0.7 Hz, 1H, CH), 7.44 (td, *J* = 7.3 Hz, *J* = 1.4 Hz, 1H, CH), 7.62 (s, 1H, CH), 8.08 (s, 1H, CH). ^13^C-NMR (CDCl~3~): δ 26.5 (NCH~3~), 28.8(NCH~3~), 62.7 (CH), 65.0 (C), 106.8 (CH), 108.9 (CH), 109.0 (CH), 122.2 (CH), 122.3 (C), 123.2 (CH), 128.8 (C), 130.8 (CH), 136.4 (C), 141.5 (C), 141.7 (C), 144.8 (CH), 154.2 (CO), 169.6 (CO). Anal. Calcld for C~18~H~13~N~3~O~6~ (367.31) C, 58.86; H, 3.57; N, 11.44. Found: C, 58.85; H, 3.71; N, 11.31.

*1-Methyl-3\'-(3-methyl-6-nitro-2-oxo-2,3-dihydrobenzo\[d\]oxazol-5-yl)spiro\[indoline-3,2\'-oxiran\]-2-one* (**7j**) *unlike*-isomer: Beige solid; mp 211 °C; ^1^H-NMR (CDCl~3~): δ 3.33 (s, 3H, NCH~3~), 3.59 (s, 3H, NCH~3~), 5.18 (s, 1H, CH), 6.01 (d, *J* = 7.5 Hz, 1H, CH), 6.71 (t, *J* = 7.5 Hz, 1H, CH), 6.88 (d, *J* = 7.7 Hz, 1H, CH), 7.32 (d, *J* = 7.7 Hz, 1H, CH), 7.57 (s, 1H, CH), 8.08 (s, 1H, CH). ^13^C-NMR (CDCl~3~): δ 26.8 (NCH~3~), 29.0 (NCH~3~), 62.2 (CH), 64.4 (C), 107.3 (CH), 107.8 (CH), 109.2 (CH), 119.8 (C), 122.0 (CH), 122.4 (CH), 129.4 (C), 130.9 (CH), 137.0 (C), 141.8 (C), 141.9 (C), 145.6 (C), 154.0 (CO), 170.6 (CO). HRMS (EI): calcd for C~18~H~13~N~3~O~6~ (M^+^) 368.0877, found 368.0876.

4. Conclusions
==============

In conclusion, we have investigated the reactivity of some new benzoxazolone derivatives formed via the TDAE strategy. This is the first example of the use of the TDAE strategy to generate a benzoxazolinonic anion, which cannot be formed via the standard organometallic strategy. This study brought to light a new and original reactivity and we have defined some limitations of the TDAE strategy. We show that 5-(bromomethyl)-3-methyl-6-nitrobenzo\[*d*\]oxazol-2(3*H*)-one (**2**), in addition to providing the expected alcohols **5a**--**i** in moderate to good yields, furnished an unexpected ester **6** formed in 23% yield, particularly with the *p*-nitrobenzaldehyde. The reactions of 5-(dibromomethyl)-3-methyl-6-nitro-benzo\[*d*\]oxazol-2(3*H*)-one (**3**) led to the expected oxiranes **7a**--**j** and mixtures of original stereoisomers **7i**--**j** in good yields. All these synthesized products are currently undergoing pharmacological evaluation.
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